在患有前列腺癌的男性接受雄激素缺乏治疗后冠状动脉斑块进展:一项随机临床试验
Sagar A Patel1,2, Adithya K Yadalam3, Marly van Assen4
1Department of Radiation Oncology, Emory University, Atlanta, Georgia.
JAMA cardiology
|February 18, 2026
概括
使用GnRH激动剂的雄激素剥夺疗法 (ADT) 在前列腺癌患者中导致冠状动脉斑块的进展比使用GnRH对抗剂更多. 这一发现可能解释ADT相关的心血管风险.
科学领域:
- 心血管医学 心血管医学
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 前列腺癌 (PCa) 的雄激素剥夺疗法 (ADT) 与心血管 (CV) 问题有关,但机制尚不清楚.
- 关于GnRH激动剂对抗剂的心血管安全性的研究有相互矛盾的结果.
研究的目的:
- 为了调查ADT是否加速冠状动脉样硬化.
- 为了比较GnRH激动剂对抗剂对冠状动脉斑块进展的影响.
主要方法:
- 一项开放的随机临床试验,涉及非转移性PCa的男性接受盆腔放射治疗和ADT.
- 患者被随机分配,接受GnRH激动剂普罗利德或GnRH抗剂relugolix.
- 冠状动脉斑块体积在基线和12个月使用CT血管造影进行评估.
主要成果:
- 与Relugolix相比,Leuprolide在12个月内与总斑块体积 (TPV) 和非化斑块体积 (NCPV) 的显著增加有关.
- 增加NCPV是斑块进展的主要驱动因素.
- 两组之间化斑块体积 (CPV) 或低衰减斑块体积 (LAPV) 没有显著差异.
结论:
- 在接受ADT的PCa男性中,GnRH激动剂普罗利德加速了冠状动脉斑块的进展,超过了GnRH对抗剂relugolix.
- 这种加速的进展,特别是在非化斑块中,可能是ADT相关的心血管风险的基础.
相关概念视频
Coronary Artery Disease III: Clinical Manifestations
437
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
437
Coronary Artery Disease IV: Preventive Measures
741
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Coronary Artery Disease II: Pathophysiology
646
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
646
Coronary Artery Disease V: Interprofessional Care
315
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
315
Coronary Artery Disease I: Introduction
1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies
309
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309


